
    
      The study will be carried out in 8 tier-3A hospitals throughout China. Patients who are at
      high risk of developing colorectal cancer and willing to conduct colonoscopy examination will
      be asked to collect stool sample prior to bowl preparation for multitarget FIT-DNA test and
      commercially available FIT assay. Colonoscopy and histopathologic examination are used as
      reference.
    
  